🇺🇸 FDA
Pipeline program

CLS2901C (human [allogeneic] chondrocyte sheets)

CLS2901-OAK-01

Phase 3 mab active

Quick answer

CLS2901C (human [allogeneic] chondrocyte sheets) for Osteoarthritis of the Knee is a Phase 3 program (mab) at CellSeed Europe Ltd with 1 ClinicalTrials.gov record(s).

Program details

Company
CellSeed Europe Ltd
Indication
Osteoarthritis of the Knee
Phase
Phase 3
Modality
mab
Status
active

Clinical trials